Safe Formulations Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
- Paid Up Capital ₹ 9.00 M
- Company Age 31 Year, 15 Days
- Last Filing with ROC 31 Mar 2018
- Revenue Growth -16.75%
- Profit Growth -38.60%
- Ebitda 131.27%
- Net Worth 3.56%
- Total Assets 23.65%
About Safe Formulations
Safe Formulations Limited (SFL) is a leading Public Limited Indian Non-Government Company incorporated in India on 25 January 1994 and has a history of 31 years. Its registered office is in Guntur, Andhra Pradesh, India.
The Corporate was formerly known as Safe Formulations Limited. The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 9.00 M, as per Ministry of Corporate Affairs (MCA) records.
Company Details
-
Location
Guntur, Andhra Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24230AP1994PLC016927
-
Company No.
016927
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
25 Jan 1994
-
Date of AGM
18 Aug 2018
-
Date of Balance Sheet
31 Mar 2018
-
Listing Status
Unlisted
-
ROC Code
Roc-Vijayawada
Industry
What products or services does Safe Formulations Limited offer?
Safe Formulations Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Mineral Supplement, Third Party Manufacturing Consultancy, Contract Manufacturing Services, Pharma & Bioanalytical Services, PCD Pharma Franchise, Trade Consultation Service, Export Consultants.
Who are the key members and board of directors at Safe Formulations?
Board Members
No Directors or KMP associated with company. Upon reviewing the records, we can confirm that there are no Directors or Key Management Personnel (KMP) associated with this company at present.
Financial Performance of Safe Formulations.
Safe Formulations Limited, for the financial year ended 2018, experienced significant reduction in revenue, with a 16.75% decrease. The company also saw a substantial fall in profitability, with a 38.6% decrease in profit. The company's net worth moved up by a moderate rise of 3.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Safe Formulations?
In 2018, Safe Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Safe Formulations?
Unlock and access historical data on people associated with Safe Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Safe Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Safe Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
